In Skov-3 and OVCAR-8 ovarian cancer cells, cisplatin treatment strongly activates PXR-mediated transcription through binding with the MDR1/CYP3A4 responsive element 72, 131. This evidence concerns the gene NR1I2 and ovarian cancer.